Aleph FarmsVBL TherapeuticsESCO Aster
| VBLTDelisted Stock | USD 0.28 0.01 3.45% |
Slightly above 61% of Vascular Biogenics' investor base is looking to short. The analysis of current outlook of investing in Vascular Biogenics suggests that many traders are alarmed regarding Vascular Biogenics' prospects. Vascular Biogenics' investing sentiment can be driven by a variety of factors including economic data, Vascular Biogenics' earnings reports, geopolitical events, and overall market trends.
Vascular |
--Aleph FarmsVBL Therapeutics Aleph FarmsESCO Ast
Read at businesswire.com
 |
Vascular Biogenics Fundamental Analysis
We analyze Vascular Biogenics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vascular Biogenics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vascular Biogenics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
Vascular Biogenics is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Vascular Biogenics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vascular Biogenics stock to make a market-neutral strategy. Peer analysis of Vascular Biogenics could also be used in its relative valuation, which is a method of valuing Vascular Biogenics by comparing valuation metrics with similar companies.
Peers
Vascular Biogenics Related Equities
| VRAX | Virax Biolabs | 27.98 | ||||
| ZVSA | ZyVersa Therapeutics | 0.81 | ||||
| TERN | Terns Pharmaceuticals | 0.70 | ||||
| HOOK | Hookipa Pharma | 1.08 | ||||
| XFOR | X4 Pharmaceuticals | 1.33 | ||||
| REVB | Revelation Biosciences | 1.54 | ||||
| ABOS | Acumen Pharmaceuticals | 2.63 | ||||
| DAWN | Day One | 3.10 | ||||
| ZURA | Zura Bio | 3.10 | ||||
| ATXI | Avenue Therapeutics | 3.40 | ||||
| ALLR | Allarity Therapeutics | 3.77 | ||||
| RNAZ | Transcode Therapeutics | 4.12 | ||||
| INZY | Inozyme Pharma | 5.86 | ||||
| PHIO | Phio Pharmaceuticals | 6.60 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Vascular Stock
If you are still planning to invest in Vascular Biogenics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Biogenics' history and understand the potential risks before investing.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |